$1.84
-0.08 (-4.17%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,897.3% upside
Low Target
$26.33
Average Target
$36.75
High Target
$40.94
Current Price
$1.84
Current
$1.84
$1.84
Target
$36.75
$36.75
$26.33
$36.75 avg
$40.94
Scenario Analysis
Bear Case
$26.33
1,331.0%
Low target
Base Case
$36.75
+1,897.3%
Avg target
Bull Case
$40.94
+2,125.0%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$31.50
-94.2% from high
52-Week Low
$1.68
+9.5% from low
Target vs 52W High
$36.75
+16.7% vs high
Next Earnings Report
Aug 27, 2026
11d
until earnings
EPS Est: $-0.31
Earnings in 11 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |